Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Lab on a Chip|December 19, 2014
A lung-on-a-chip array with an integrated bio-inspired respiration mechanismAndreas O Stucki, Janick D Stucki, Sean R R Hall, et al.Transplantation|October 1, 1977
Immunosuppression with polyunsaturated fatty acids in renal transplantationM I McHugh, R Wilkinson, R W Elliott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancerK N Qureshi, T R Griffiths, M C Robinson, et al.Cancers|April 3, 2021
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaHaitang Yang, Sean R R Hall, Beibei Sun, et al.European Urology|November 24, 1999
Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study GroupW P Witjes, M König, F P Boeminghaus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fosså, P H Slee, M Brausi, et al.European Urology|January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinomaK H Kurth, F M Debruyne, R R Hall, et al.Cell Death & Disease|July 17, 2015
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancerS-Q Liang, T M Marti, P Dorn, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|February 20, 2017
Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitroRebecca A M Blom, Mario Amacker, Christian Moser, et al.Theranostics|January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesotheliomaHaitang Yang, Sabina Berezowska, Patrick Dorn, et al.Pageof 10